Academic literature on the topic 'Bacteria Bacteria Drug resistance in microorganisms. Staphylococcus'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bacteria Bacteria Drug resistance in microorganisms. Staphylococcus.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Bacteria Bacteria Drug resistance in microorganisms. Staphylococcus"
Liu, Yutong, and Xuanrong Xu. "Drug Resistance of Ocular Bacteria Considering Biofilm Mechanism." E3S Web of Conferences 271 (2021): 03041. http://dx.doi.org/10.1051/e3sconf/202127103041.
Full textKoulenti, Despoina, Elena Xu, Andrew Song, Isaac Yin Sum Mok, Drosos E. Karageorgopoulos, Apostolos Armaganidis, Sotirios Tsiodras, and Jeffrey Lipman. "Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms." Microorganisms 8, no. 2 (January 30, 2020): 191. http://dx.doi.org/10.3390/microorganisms8020191.
Full textYang, Yong, Olga Babich, Stanislav Sukhikh, Mariya Zimina, and Irina Milentyeva. "Antibiotic activity and resistance of lactic acid bacteria and other antagonistic bacteriocin-producing microorganisms." Foods and Raw Materials 8, no. 2 (September 30, 2020): 377–84. http://dx.doi.org/10.21603/2308-4057-2020-2-377-384.
Full textJankowiak, Emilia, Łukasz Kubera, Marta Małecka-Adamowicz, and Ewa Dembowska. "Microbiological air quality in pharmacies and an antibiotic resistance profile of staphylococci species." Aerobiologia 36, no. 4 (July 10, 2020): 551–63. http://dx.doi.org/10.1007/s10453-020-09651-x.
Full textNoor, Rashed, Syeda Muntaka Maniha, Taskina Murshed, and M. Majibur Rahman. "Effectiveness of Antibiotics: Anti-Bacterial Activity or Microbial Drug Resistance?" Bangladesh Journal of Microbiology 36, no. 2 (February 19, 2020): 111–14. http://dx.doi.org/10.3329/bjm.v36i2.45537.
Full textAfrin, Sarah, Priyanka Basak, and Tasmina Rahman. "Demonstration of drug-resistant bacteria among commonly available flowers within Dhaka Metropolis and assessment of their anti-bacterial properties." Stamford Journal of Microbiology 5, no. 1 (March 1, 2016): 5–8. http://dx.doi.org/10.3329/sjm.v5i1.26911.
Full textGobbo, Jessica Lais, Marita Vedovelli Cardozo, Luciana De Cenço Corrêa de Lacerda, Débora Emy Karcher, Luís Gustavo Gosuen Gonçalves Dias, Andrigo Barboza de Nardi, Bruno Watanabe Minto, and Paola Castro Moraes. "Evaluation of Operating Room Environment Contamination and Efficacy of 2% Chlorhexidine for Surgical Hand Scrubbing before and after Gowning and Gloving." Acta Scientiae Veterinariae 45, no. 1 (September 15, 2017): 10. http://dx.doi.org/10.22456/1679-9216.80500.
Full textStojanov, Igor M., Milica M. Živkov Baloš, Miloš C. Kapetanov, Jasna Z. Prodanov Radulović, and Jelena M. Petrović. "BACTERIA IN ANIMAL FEED AND THEIR SUSCEPTIBILITY TO ANTIMICROBIAL DRUGS." Archives of Veterinary Medicine 5, no. 2 (December 1, 2012): 27–33. http://dx.doi.org/10.46784/e-avm.v5i2.168.
Full textNascimento, Thiago César, Vânia Lúcia Da Silva, Alessandra Barbosa Ferreira-Machado, and Cláudio Galuppo Diniz. "Potential spread of multidrug-resistant coagulase-negative staphylococci through healthcare waste." Journal of Infection in Developing Countries 9, no. 01 (January 15, 2015): 029–34. http://dx.doi.org/10.3855/jidc.4563.
Full textNaher, Akhtarun, Sadia Afroz, and Shahida Hamid. "Cockroach Associated Foodborne Pathogens: Distribution and Antibiogram." Bangladesh Medical Research Council Bulletin 44, no. 1 (June 6, 2018): 30–38. http://dx.doi.org/10.3329/bmrcb.v44i1.36802.
Full textDissertations / Theses on the topic "Bacteria Bacteria Drug resistance in microorganisms. Staphylococcus"
Dupree, Tom. "Pharmacophore development and validation for inhibitors of the bacterial NorA efflux pump." Access electronically, 2005. http://www.library.uow.edu.au/adt-NWU/public/adt-NWU20060725.152339/index.html.
Full textKassem, Issmat I. "Detection and Characterization of Staphylococcal Pathogens in the Environment: A Community Approach." Connect to full text in OhioLINK ETD Center, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=toledo1241717899.
Full textTypescript. "Submitted in partial fulfillment of the requirements for The Doctor of Philosophy in Biology (Ecology-Track)." Bibliography: leaves 108-126.
Adegoke, Anthony Ayodeji. "Commensal bacteria belonging to the Staphylococcus Acinetobacter and Stenotrophomonas genera as reservoirs of antibiotic resistance determinants in the environment of Nkonkobe Municipality, Eastern Cape Province , South Africa." Thesis, University of Fort Hare, 2012. http://hdl.handle.net/10353/6539.
Full textYakobi, Sinethemba Hopewell. "The level and persistence of antibiotic resistant strains of bacteria in wastewater before, during and after treatment at a municipal wastewater treatment plant in Stellenbosch." Thesis, Cape Peninsula University of Technology, 2015. http://hdl.handle.net/20.500.11838/2237.
Full textWastewater treatment plants (WWTPs) are designed to remove/decrease conventional pollution parameters from the wastewater influent, so that the final effluent (run off) does not compromise the receiving surface water source. However, as hospital and clinical effluent may form part of the initial influent at a WWTP, bacteria may be exposed to various antibiotics or pharmaceuticals throughout the various stages of primary, secondary and tertiary processes utilised to remove or reduce the level of pollutants. Numerous studies have then indicated that WWTPs have become potential reservoirs for antibiotic resistant bacteria (ARB) and due to ineffective treatment practices, antibiotics are being released into the environment. Consequently, research has shown that relatively low concentrations of these compounds still promotes the development of bacterial resistance, which potentiates the rapid spread of ARB in the environment. The primary aim of this study was thus to identify and trace the antibiotic resistant strains of Staphylococcus aureus (S. aureus), Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) throughout the Stellenbosch WWTP. This was done in order to determine the persistance of the ARB organisms at the various stages of treatment and to ascertain which identification and antibiotic resistance detection methods are ideal for the routine application and detection of these organisms.
National Research Foundation
Roe, Darcie Elizabeth. "Prevalence and mechanisms of antibiotic resistance in oral bacteria." Thesis, Connect to this title online; UW restricted, 1996. http://hdl.handle.net/1773/9310.
Full textSmith, Lisa Marie. "Antibiotic resistance and coliform bacteria in the Ohio River; 2002 to 2004." Huntington, WV : [Marshall University Libraries], 2006. http://www.marshall.edu/etd/descript.asp?ref=679.
Full textTitle from document title page. Includes abstract. Document formatted into pages: contains vii, 73 p. including illustrations and maps. Bibliography: p. 25-28.
Fusté, i. Domínguez Ester. "Epigenetics of Antimicrobial Resistance in Gram-Negative Bacteria." Doctoral thesis, Universitat de Barcelona, 2012. http://hdl.handle.net/10803/97096.
Full textEs van explorar els mecanismes no convencionals de resistència als agents antimicrobians que contribueixen a l’aparició de fenotips multiresistents en els bacteris Gram-negatius Serratia marcescens i Pseudomonas aeruginosa. Es van examinar també els canvis en la susceptibilitat als agents antimicrobians en S. marcescens durant els darrers 50 anys, comparant soques aïllades entre els anys 1945-1950 y soques actuals. ¬Les principals conclusions obtingudes d’aquest estudi són les següents: 1. El resistoma de Serratia marcescens no ha canviat significativament des de l’era pre-antibiòtica fins l’actualitat. 2. La retirada dels antibiòtics tendeix a recuperar els fenotips de susceptibilitat originals, independentment del mecanisme molecular implicat en la resistència. 3. Cap de las soques de Serratia estudiades va presentar integrons ni tampoc ß-lactamases d’espectre estès. 4. La determinació fenotípica de les susceptibilitats de las soques “antigues” de Serratia inactives durant 60 anys ha confirmat els resultats obtinguts mitjançant metagenòmica, és a dir, els gens de resistència als antibiòtics ja existien amb anterioritat al descobriment i ús dels antibiòtics. 5. En les soques clíniques de P. aeruginosa multiresistents es va detectar un integró de classe 1 que contenia el cassette gènic aadB, que codifica l’enzim aminoglicòsid 2’-O- adeniltransferasa, que confereix resistència a gentamicina, tobramicina i kanamicina. 6. Les soques multiresistents de P. aeruginosa van sobreexpressar els sistemes de reflux MexAB-OprM i MexXY-OprM. 7. L’ús de l’inhibidor de bombes de reflux CCCP s’hauria d’evitar als experiments realitzats amb P. aeruginosa i probablement amb altres bacteris de metabolisme aeròbic. 8. El meropenem indueix la formació de llargs bacils aberrants capaços de sobreviure en presència de l’antibiòtic. Aquests bacils acumulen menys antibiòtic que els bacteris normals, i poden revertir a la forma normal quan s’elimina la pressió selectiva. 9. La colistina, la última alternativa terapèutica per lluitar contra P. aeruginosa en pacients amb fibrosis quística, és normalment efectiva, encara que recentment han sorgit casos de resistència a aquest agent antimicrobià. 10. La resistència a colistina sembla estar causada per propietats singulars del lipopolisacàrid. 11. La colistina produeix danys en les membranes lipídiques que poden ser estudiats mitjançant tècniques de Black lipid bilayer. Estudis preliminars van mostrar la capacitat de la colistina para induir canals transitoris en les bicapes lipídiques, amb certa dependència de voltatge. 12. La recuperació de la susceptibilitat a l’imipenem en P. aeruginosa és més lenta que l’adquisició de resistència, donat que l’avantatge selectiva conferida per la resistència a l’imipenem en presència de l’agent antimicrobià és forta, mentre que l’expressió d’ OprD és probablement avantatjosa solament sota certes i desconegudes condicions ambientals.
Se exploraron los mecanismos no convencionales de resistencia a agentes antimicrobianos que contribuyen a la aparición de fenotipos multiresistentes en las bacterias Gram-negativas Serratia marcescens y Pseudomonas aeruginosa. Se examinaron también los cambios en la susceptibilidad a los agentes antimicrobianos en S. marcescens en los últimos 50 años, comparando cepas aisladas entre los años 1945-1950 y cepas actuales. ¬Las principales conclusiones obtenidas de este estudio son las siguientes: 1. El resistoma de Serratia marcescens no ha cambiado significativamente desde la era pre-antibiótica hasta la actualidad. 2. La retirada de los antibióticos tiende a recuperar los fenotipos de susceptibilidad originales, independientemente del mecanismo molecular implicado en la resistencia. 3. Ninguna de las cepas de Serratia estudiadas presentó integrones ni tampoco ß-lactamasas de espectro extendido. 4. La determinación fenotípica de las susceptibilidades de las cepas “antiguas” de Serratia inactivas durante 60 años ha confirmado los resultados obtenidos mediante metagenómica, es decir, los genes de resistencia a los antibióticos ya existían con anterioridad al descubrimiento y uso de los antibióticos. 5. En las cepas clínicas de P. aeruginosa multiresistentes se detectó un integrón de clase 1 que contenía el cassette génico aadB, que codifica la enzima aminoglicósido 2’-O- adeniltransferasa, que confiere resistencia a gentamicina, tobramicina y kanamicina. 6. Las cepas multiresistentes de P. aeruginosa sobreexpresaron los sistemas de reflujo MexAB-OprM y MexXY-OprM. 7. El uso del inhibidor de bombas de reflujo CCCP se debería evitar en los experimentos realizados con P. aeruginosa y probablemente con otras bacterias de metabolismo aeróbico. 8. El meropenem induce la formación de largos bacilos aberrantes capaces de sobrevivir en presencia del antibiótico. Estos bacilos acumulan menos antibiótico que las bacterias normales, y pueden revertir a la forma normal cuando se elimina la presión selectiva. 9. La colistina, la última alternativa terapéutica para luchar contra P. aeruginosa en pacientes con fibrosis quística, es normalmente efectiva, aunque recientemente han surgido casos de resistencia a este agente antimicrobiano. 10. La resistencia a colistina parece estar mediada por propiedades singulares del lipopolisacárido. 11. La colistina produce daños en las membranas lipídicas que pueden ser estudiados mediante técnicas de Black lipid bilayer. Estudios preliminares mostraron la capacidad de la colistina para inducir canales transitorios en las bicapas lipídicas, con cierta dependencia de voltaje. 12. La recuperación de la susceptibilidad al imipenem en P. aeruginosa es más lenta que la adquisición de resistencia, dado que la ventaja selectiva conferida por la resistencia al imipenem en presencia del agente antimicrobiano es fuerte, mientras que la expresión de OprD es probablemente ventajosa sólo bajo ciertas y desconocidas condiciones ambientales.
Hunt, Kevan Owen. "An epidemiological study in the greater Durban area of gram negative bacilli resistant to aminoglycoside antibiotics." Thesis, Cape Technikon, 1998. http://hdl.handle.net/20.500.11838/2254.
Full textThis study was undertaken to investigate resistance to aminoglycoside antibiotics and the transfer of resistance in selected Gram negative bacilli in hospitals in the Greater Durban area in order to determine whether the development of resistance in this region was similar to that found in other countries and whether it was the same in the hospitals in the region. It was intended that the study might expose the existence of nosocomial pathogens of a particular strain or endemic plasmids responsible for aminoglycoside antibiotic resistance. Strains of Klebsiella, Enterobacter and Serratia species and Escherichia coli resistant to gentamicin, tobramycin, netilmicin or amikacin were obtained. Resistance of the isolates obtained to the above aminoglycoside antibiotics was confirmed using a disc diffusion technique. Resistance mechanisms were initially assigned on the basis of resistance to these four aminoglycoside antibiotics. In approximately 50% of the isolates, including donor isolates and their respective transconjugants, resistance mechanisms were confirmed or revised on the basis of a changed resistance profile to a range of 12 aminoglycoside antibiotics in conjunction with DNA/DNA hybridization tests. Bacterial conjugation studies were performed on selected isolates to investigate the transfer of aminoglycoside resistance from Klebsiella pneumoniae isolates to recipient Escherichia coli. Plasmid profiles of all isolates and Escherichia colitransconjugants were compared to establish similarities. Isolates in three of the four genera of bacteria and all isolates collectively, demonstrated the greatest incidence of resistance to tobramycin. Amikacin resistance was, in all groups of isolates, the least frequently encountered. Collectively, the most frequent mechanisms of resistance were the AAC(3)-V and AAC(6')-1 enzymes One large hospital showed a high frequency of the AAC(3)-V modifying enzyme while in other hospitals a wider range of enzyme resistance mechanisms were evident. Plasmid profiles were generally dissimilar within and between different genera and the different hospitals.
Mangosuthu Technikon Research Fund
Leng, Zhongtai. "Distribution and mobility of antibiotic resistant genes in oral/urogentital [sic] bacteria." Thesis, Connect to this title online; UW restricted, 1998. http://hdl.handle.net/1773/9273.
Full textSeanego, Christinah Tshephisho. "Phytochemical analysis and bioactivity of Garcinia Kola (Heckel) seeds on selected bacterial pathogens." Thesis, University of Fort Hare, 2012. http://hdl.handle.net/10353/420.
Full textBooks on the topic "Bacteria Bacteria Drug resistance in microorganisms. Staphylococcus"
Baddour, Manal M. MRSA (methicillin resistant Staphylococcus Aureus) infections and treatment. New York: Nova Science Publishers, 2010.
Find full textNoskin, Gary A. Contemporary diagnosis and management of antimicrobial-resistant bacteria. Newtown, Pennsylvania, USA: Handbooks in Health Care Co., 2008.
Find full textYi, Kyŏng-wŏn. Hangsaengje naesŏng kyunju ŭnhaeng kuchuʻk =: Establishment of culture collection of antimicrobial resistant bacteria. [Seoul: Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.
Find full textRising plague: The global threat from deadly bacteria and our dwindling arsenal to fight them. Amherst, N.Y: Prometheus Books, 2009.
Find full textC, Crabbe M. James, ed. Bacteria and anti-bacterical agents. Oxford: Spektrum, 1996.
Find full textYi, Yŏng-sŏn. Chiyŏk sahoe nae hangsaengje naesŏng yŏnghyang pʻyŏngka =: Effective evaluations of antimicrobial resistant pathogens within the community. [Seoul]: Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.
Find full textDrug-resistant diseases and superbugs. Tarrytown, NY: Marshall Cavendish Benchmark, 2010.
Find full textAmábile-Cuevas, Carlos F. Origin, evolution and spread of antibiotic resistance genes. Austin: R.G. Landes Co., 1993.
Find full text1946-, Chopra I., ed. Understanding antibacterial action and resistance. 2nd ed. London: Ellis Horwood, 1996.
Find full textBook chapters on the topic "Bacteria Bacteria Drug resistance in microorganisms. Staphylococcus"
Sapula, Sylvia A., and Melissa H. Brown. "Antimicrobial Drug Efflux Pumps in Staphylococcus aureus." In Efflux-Mediated Antimicrobial Resistance in Bacteria, 165–95. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39658-3_7.
Full textKalia, Nitin Pal. "Efflux-Mediated Drug Resistance in Staphylococcus aureus." In Drug Resistance in Bacteria, Fungi, Malaria, and Cancer, 307–23. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48683-3_13.
Full textMukherjee, Riya, Anjali Priyadarshini, Ramendra Pati Pandey, and Vethakkani Samuel Raj. "Antimicrobial Resistance in Staphylococcus aureus." In Staphylococcus aureus [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96888.
Full textSingh, Atamjit, Kirandeep Kaur, Pallvi Mohana, Avneet Kaur, Komalpreet Kaur, Shilpa Heer, Saroj Arora, Neena Bedi, and Preet Mohinder Singh Bedi. "Mechanistic Insights of Drug Resistance in Staphylococcus Aureus with Special Reference to Newer Antibiotics." In Staphylococcus aureus [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.100045.
Full textUlrich Picoli, Simone, Nicole Mariele Santos Röhnelt, and Tiago Sfredo Schenkel. "Bacteriophages as Anti-Methicillin Resistant Staphylococcus aureus Agents." In Staphylococcus aureus [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.98313.
Full text